학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 107건 | 목록 1~20
Academic Journal
Dummer R; Department of Dermatology, Skin Cancer Unit, University Hospital Zurich, Zurich, Switzerland.; Sandhu S; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Australia.; Miller WH Jr; Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.; Department of Medicine, McGill University, Montreal, Canada.; Department of Oncology, McGill University, Montreal, Canada.; Butler MO; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.; Department of Immunology, University of Toronto, Toronto, Canada.; Taylor MH; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Heinzerling L; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University, Munich, Germany.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Muñoz-Couselo E; Department of Medical Oncology, Melanoma and Other Skin Cancers Unit, Vall d'Hebron Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee.; Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.; Chmielowski B; Division of Hematology-Oncology, Department of Medicine, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Middleton MR; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, United Kingdom.; Berking C; Department of Dermatology, Uniklinikum Erlangen, CCC Erlangen - EMN, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Hassel JC; Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University, Medical Faculty Heidelberg, NCT Heidelberg, A Partnership Between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.; Gesierich AH; Department of Dermatology, Venerology and Allergology, University Hospital Würzburg, Würzburg, Germany.; Mauch C; Department of Dermatology and Venereology, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.; Kleha JF; Pfizer, New York, New York.; Polli A; Pfizer, Milan, Italy.; Harney AS; Pfizer Boulder Research Unit, Boulder, Colorado.; di Pietro A; Pfizer, Milan, Italy.; Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Taylor MH; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA xiaomin.schebye@immuneonc.com matthew.taylor@providence.org.; Naing A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Powderly J; Carolina BioOncology Institute, Huntersville, North Carolina, USA.; Woodard P; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Chung L; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Lin WH; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Tian H; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Siemers N; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Xiang H; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Deng R; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Hong K; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Valencia D; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Huang T; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Zhu Y; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Liao XC; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA.; Schebye XM; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA xiaomin.schebye@immuneonc.com matthew.taylor@providence.org.; Patel MR; Florida Cancer Specialists/ Sarah Cannon Research Institute, Sarasota, Florida, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Editorial & Opinion
Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Yogesh Shah A; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.; Rao A; Division of Hematology and Oncology, East Park Medical Group, Houston, TX, USA.; Taylor MH; Division of Hematology and Oncology, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.; Di Simone C; Medical Oncology/Hematology, Arizona Oncology Associates, Tucson, AZ, USA.; Hsieh JJ; Department of Medicine, Oncology Division, Washington University School of Medicine, St. Louis, MO, USA.; Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain.; Gironés Sarrió R; Medical Oncology Service, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Lee Cohn A; Medical Oncology, US Oncology Research, Rocky Mountain Cancer Center, Denver, CO, USA.; Asim Bilen M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Gunnestad Ribe S; Medical Oncology, Sorlandet Hospital Kristiansand, Kristiansand, Norway.; Krohn Tennøe Ø; Sykehuset Østfold, Sarpsborg, Norway.; Richards D; Department of Oncology, US Oncology Research, Texas Oncology-Tyler, Tyler, TX, USA.; Sweis RF; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.; Courtright J; Department of Oncology, US Oncology Research, Texas Oncology, Dallas, TX, USA.; Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.; Perini R; Clinical Research, Merck & Co. Inc, Rahway, NJ, USA.; Kubiak P; Clinical Research, Eisai Inc, Nutley, NJ, USA.; Bock D; Biostatistics, Eisai Inc, Nutley, NJ, USA.; Okpara CE; Clinical Research, Eisai Ltd, Hatfield, UK.; Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: motzerr@mskcc.org.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: In Process; MEDLINE
Academic Journal
Gelderblom H; Leiden University Medical Center, Leiden, Netherlands.; Razak AA; Princess Margaret Cancer Center, Toronto, Canada.; Taylor MH; Earle A. Chiles Research Institute, Providence Medical Center, Portland, Oregon.; Bauer TM; Tennessee Oncology, Nashville, Tennessee.; Wilky B; University of Colorado Cancer Center, Aurora, Colorado.; Martin-Broto J; Fundación Jiménez Díaz University Hospital, University Hospital General de Villalba, Instituto de Investigactión Sanitaria Fundación Jiménez Díaz (IIS, FJD, UAM), Madrid, Spain.; Gonzalez AF; Virgen del Rocío University Hospital, Seville, Spain.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.; Szostakowski B; Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland.; Alcindor T; McGill University Health Centre Research Institute, Montreal, Canada.; Saleh R; McGill University Health Centre Research Institute, Montreal, Canada.; Genta S; Princess Margaret Cancer Center, Toronto, Canada.; Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; van de Sande M; Leiden University Medical Center, Leiden, Netherlands.; Wagner AJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Bernthal N; University of California Los Angeles, Los Angeles, California.; Davis LE; OHSU Knight Cancer Institute, Portland, Oregon.; Vuky J; OHSU Knight Cancer Institute, Portland, Oregon.; Tait C; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Matin B; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Narasimhan S; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Sharma MG; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Ruiz-Soto R; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Sherman ML; Deciphera Pharmaceuticals, LLC, Waltham, Massachusetts.; Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Yaeger R; Memorial Sloan Kettering Cancer Center, New York, New York.; McKean MA; Sarah Cannon Research Institute, Nashville, Tennessee.; Haq R; Dana Farber Cancer Institute, Boston, Massachusetts.; Beck JT; Highlands Oncology, Fayetteville, Arkansas.; Taylor MH; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Cohen JE; Hadassah Medical Center, Jerusalem, Israel.; Bowles DW; University of Colorado Hospital, Aurora, Colorado.; Gadgeel SM; Henry Ford Health System, Detroit, Michigan.; Mihalcioiu C; McGill University Health Centre, Montreal, Canada.; Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas.; Diamond EL; Memorial Sloan Kettering Cancer Center, New York, New York.; Sturtz KB; Pfizer Boulder Research and Development, Boulder, Colorado.; Feng G; Pfizer Early Clinical Development, Cambridge, Massachusetts.; Drescher SK; Pfizer Boulder Research and Development, Boulder, Colorado.; Reddy MB; Pfizer Boulder Research and Development, Boulder, Colorado.; Sengupta B; Pfizer Boulder Research and Development, Boulder, Colorado.; Maity AK; Pfizer Early Clinical Development, Cambridge, Massachusetts.; Brown SA; Pfizer Boulder Research and Development, Boulder, Colorado.; Singh A; Pfizer Boulder Research and Development, Boulder, Colorado.; Brown EN; Pfizer Boulder Research and Development, Boulder, Colorado.; Baer BR; Pfizer Boulder Research and Development, Boulder, Colorado.; Wong J; Pfizer Boulder Research and Development, Boulder, Colorado.; Mou TC; Pfizer Boulder Research and Development, Boulder, Colorado.; Wu WI; Pfizer Boulder Research and Development, Boulder, Colorado.; Kahn DR; Pfizer Boulder Research and Development, Boulder, Colorado.; Gadal S; Memorial Sloan Kettering Cancer Center, New York, New York.; Rosen N; Memorial Sloan Kettering Cancer Center, New York, New York.; Gaudino JJ; Pfizer Boulder Research and Development, Boulder, Colorado.; Lee PA; Pfizer Boulder Research and Development, Boulder, Colorado.; Hartley DP; Pfizer Boulder Research and Development, Boulder, Colorado.; Rothenberg SM; Pfizer Boulder Research and Development, Boulder, Colorado.; Pfizer Oncology Research and Development, La Jolla, California.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Taylor, Matthew H
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어